Loading...

CLSD CLEARSIDE BIOMEDICAL INC Delisting Actions 8-K Filing

CLRS

CLSD

CLEARSIDE BIOMEDICAL INC

(CLSD)

2025 8-K

Show Summary

Summary

Delisting Notice

Management Changes

Financial Statements

Financial Results

Nasdaq Compliance Notice

Corporate Presentation

Financial Results

Positive Trial Results

Financial Results

Webinar Presentation

Annual Meeting of Stockholders

Appointment of Director

Registered Direct Offering

Amendment to License Agreement

Agreement Amendment

License Agreement with BioC...

Earnings Reports

Equity Offering

Clinical Trial Announcement

Earnings Reports

Resignation and Appointment

Resignation of Officer

Results of OASIS Extension ...

External Links:

Clearside Biomedical, Inc. announced on August 14, 2025, that its common stock may be delisted from Nasdaq due to not meeting the minimum bid price requirement of $1.00 per share for 30 consecutive business days, with a hearing requested to maintain its listing. Additionally, Anthony Gibney resigned as Chairperson on August 11, 2025.

AI Assistant

CLEARSIDE BIOMEDICAL INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.